采用新型多光谱先进纳米颗粒跟踪技术对多分散脂质体制剂进行粒径分析。
Particle size analyses of polydisperse liposome formulations with a novel multispectral advanced nanoparticle tracking technology.
机构信息
U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD, USA; Laboratory of Adjuvant and Antigen Research, U S Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, USA.
HORIBA Instruments Inc, 20 Knightsbridge Rd, Piscataway Township, NJ, USA.
出版信息
Int J Pharm. 2019 Jul 20;566:680-686. doi: 10.1016/j.ijpharm.2019.06.013. Epub 2019 Jun 6.
Liposomes are potent adjuvant constituents for licensed vaccines and vaccine candidates and carriers for drug delivery. Depending on the method of preparation, liposomes vary in size distribution, either forming uniform small size vesicles or a heterogeneous mixture of small to large vesicles. Importantly, differences in liposomal size have been demonstrated to induce differential immune responses. Determination of particle size distribution could therefore be crucial for the efficacy and stability of vaccine formulations. We compared the techniques of dynamic light scattering, laser diffraction, and conventional nanoparticle tracking analysis with a novel multispectral advanced nanoparticle tracking analysis (MANTA) for particle size determination of mono- and polydisperse liposomes. MANTA reported an average 146 nm size of monodisperse liposomes but showed a multimodal distribution of polydisperse liposomes with continuous sizes from 50 to 2000 nm. However, approximately 95% of particles were in the size range of 50-1500 nm and only few particles were identified in the 1500-2000 nm range for the investigated volume. Based on our results, we conclude that MANTA is the most suitable approach and can serve as stand-alone technique for particle size characterization of heterogeneous liposome samples in the 50-2000 nm size range.
脂质体是已上市疫苗和疫苗候选物的有效佐剂成分,也是药物递送的载体。根据制备方法的不同,脂质体的粒径分布不同,可形成均匀的小粒径囊泡,也可形成小到大粒径的不均匀混合物。重要的是,脂质体的粒径差异已被证明可诱导不同的免疫反应。因此,粒径分布的测定对于疫苗制剂的功效和稳定性可能至关重要。我们比较了动态光散射、激光衍射和传统纳米颗粒跟踪分析技术与新型多光谱先进纳米颗粒跟踪分析(MANTA),用于单分散和多分散脂质体的粒径测定。MANTA 报告了单分散脂质体的平均粒径为 146nm,但显示出多分散脂质体的多模态分布,连续粒径范围为 50 至 2000nm。然而,在所研究的体积中,约 95%的颗粒处于 50-1500nm 的粒径范围内,只有少数颗粒在 1500-2000nm 的范围内被识别。基于我们的结果,我们得出结论,MANTA 是最适合的方法,可作为 50-2000nm 粒径范围内异质脂质体样品的粒径特征的独立技术。